Conflict of Interest: The authors report no conflicts of interest.
Outcomes of a Headache-Specific Cross-Sectional Multidisciplinary Treatment Program
Article first published online: 15 JUN 2012
© 2012 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 52, Issue 7, pages 1094–1105, July/August 2012
How to Cite
Wallasch, T.-M., Angeli, A. and Kropp, P. (2012), Outcomes of a Headache-Specific Cross-Sectional Multidisciplinary Treatment Program. Headache: The Journal of Head and Face Pain, 52: 1094–1105. doi: 10.1111/j.1526-4610.2012.02189.x
- Issue published online: 3 JUL 2012
- Article first published online: 15 JUN 2012
- Accepted for publication April 18, 2012.
- integrated care;
- outcome study;
- chronic headache;
Aim.— Chronic headache is a disabling disorder that is frequently poorly managed in general clinical practice.
Objectives.— To investigate primary (headache frequency in days/month) and secondary (headache-related disability, lost work/school time, anxiety and depression, amount and intake frequency of acute medication) 12-month outcomes of a headache-specific cross-sectional outpatient and inpatient multidisciplinary treatment program using a dedicated computer system for data collection and corresponding between integrated care team in a tertiary headache center and practicing headache specialists.
Background.— A need for integrated headache care using comprehensive and standardized assessment for diagnosis of headache, psychiatric comorbidity, and burden of disease exists. There are little published data on long-term efficacy of multidisciplinary treatment programs for chronic headache.
Design.— A prospective, observational, 12-month, follow-up study.
Subjects and Methods.— Prospectively recruited consecutive patients with frequent difficult-to-treat headaches (n = 201; 63 migraine, 11 tension-type headache, 59 combined migraine/tension-type headache, and 68 medication overuse headache) were enrolled. Outcome measures included prospective headache diaries, a medication survey, Migraine Disability Assessment, 12-item short form health survey, and the Hospital Anxiety and Depression Scale.
Results.— The primary outcome of a reduction of ≥50% of headache frequency (days/month) was observed in 62.7%. Mean headache frequency decreased from 14.4 ± 8.2 to 7.6 ± 8.3 days/month, P < .0001. Secondary outcomes improved significantly in the total cohort and all headache subgroups. Predictors for good outcome were younger age, few days lost at work/school, and familiarity with progressive muscle relaxation therapy at baseline.
Conclusions.— The present analysis provided support for a cross-sectional multidisciplinary integrated headache-care program.